FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine, namely to surgery. Antiadgezin 0.5 mg is intraoperatively administered to rats on injured surfaces. Injuries are performed on the parietal peritoneum from both sides, including the intestinal loops and the uterine horn until signs of hyperaemia appear.
EFFECT: method enables reducing the thickness of postoperative peritoneal adhesions in rats, reducing the portion of collagen contained in peritoneal adhesions and causing disorder of its arrangement, as well as reducing the thickness of the fibres, intensity of the local inflammatory process, enhancing tissue regeneration in the damaged area without activation of proliferative processes and without the formation of collagen adhesions, which in turn makes it possible to develop a method for preventing postoperative peritoneal adhesions in gynaecological and pelvic surgery.
1 cl, 4 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF POSTOPERATIVE ADHESIONS OF THE PERITONEUM IN THE EXPERIMENT | 2018 |
|
RU2696828C1 |
METHOD OF EXPERIMENTAL SIMULATION OF POSTOPERATIVE ADHESIVE PROCESS IN PERITONEUM | 2018 |
|
RU2677194C1 |
METHOD OF ABDOMINAL ADHESIONS PREVENTION | 2010 |
|
RU2447848C2 |
METHOD OF SIMULATING ADHESIVE PROCESSES IN ABDOMINAL CAVITY | 2016 |
|
RU2632538C1 |
METHOD OF PREVENTION OF POSTOPERATIVE ADHESIVE PROCESS OF PELVIC ORGANS | 2020 |
|
RU2745965C1 |
METHOD OF PREVENTING RECURRENCE OF PERITONEAL COMMISSURES IN PATIENTS WITH TUBE-PERITONEAL FORM OF INFERTILITY | 2010 |
|
RU2445028C2 |
NEW PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2501566C2 |
METHOD FOR PREVENTING POSTSURGICAL SEROUS CAVITY COMMISSURE FORMATION | 2002 |
|
RU2225171C2 |
METHOD OF PREVENTION OF COMMISSURE FORMATION AND RELAPSE THEREOF | 2007 |
|
RU2331367C1 |
ANTI-ADHESION MEANS | 2016 |
|
RU2645074C2 |
Authors
Dates
2025-04-30—Published
2024-03-12—Filed